Differential alteration in vascular structure of resistance arteries isolated from the cerebral and mesenteric vascular beds of transgenic [(mRen- 2)27], hypertensive rats

Hypertension

Volumn 29, Issue 5, 1997, Pages 1140-1147

  Dunn, William R ^a   Gardiner, Sheila M ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NONE

Author keywords

angiotensin; hypertension; hypertrophy; resistance arteries; romodeling

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY COMPLIANCE; ARTERY RESISTANCE; ARTICLE; BRAIN ARTERY; CONTROLLED STUDY; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRESS STRAIN RELATIONSHIP;

EID: 0030914217     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.5.1140     Document Type: Article

References (32)

1. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344: 541-544.
2. Bader M, Zhao Y, Sander M, Lee MA, Bachmann J, Bohm M, Djavidani B, Peters J, Mullins JJ, Ganten D. Role of tissue renin in the pathophysiology of hypertension in TGR (mREN2)27 rats. Hypertension. 1992;19:681-686.
3. Moriguchi A, Brosnihan KB, Kumagai H, Ganten D, Ferrario CM. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol. 1994;266:R1273-R1279.
4. Gardiner SM, March JE, Kemp PA, Mullins JJ, Bennett T. Haemodynamic effects of losartan and the endothelin antagonist. SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats. Br J Pharmacol. 1995;116:2237-2244.
5. 1 blockade in mRen2 transgenic rats. J Cardiovasc Pharmacol. 1995;27:476-481.
6. Lee MA, Bohm M, Paul M, Bader M, Ganten U, Ganten D. Physiological characterization of the hypertensive transgenic TGR(mREN2)27. Am J Physiol. 1996;270:E919-E929.
7. Hilgers KF, Peters J, Veelken R, Sommer M, Rupprecht G, Ganten D, Luft FC, Mann JFE. Increased vascular angiotensin formation in female rats harbouring the mouse Ren-2 gene. Hypertension. 1992; 19:687-691.
8. Lee MA, Bohm M, Kim S, Bachmann S, Bachmann J, Bader M, Ganten D. Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat. Hypertension. 1995; 25:570-580.
9. Djavidani B, Sander M, Kreutz R, Zeh K, Bader M, Mellon SH, Vecsei P, Peters J, Ganten D. Chronic dexamethasone treatment suppresses hypertension development in the transgenic rat TGR(mREN2)27. J Hypertens. 1995;13:637-645.
10. Arribas S, Sanchez-Ferrer CF, Piero C, Ponte A, Salaices M, Marin J. Functional vascular renin-angiotensin system in hypertensive transgenic rats for the mouse renin gene Ren-2. Gen Pharmacol. 1994;25:1163-1170.
11. Dunn WR, McGrath JC, Wilson VG. Influence of angiotensin II on the α-adrenoceptors involved in mediating the response to sympathetic nerve stimulation in the rabbit isolated distal saphenous artery. Br J Pharmacol. 1991;102:10-12.
12. Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens. 1986;4:515-524.
13. Mulvanv MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev. 1990;70:922-961.
14. Bachmann S, Peters J, Engler E, Ganten D, Mullins J. Transgenic rats carrying the mouse renin gene: morphological characterization of a low-renin hypertension model. Kidney Int. 1992;41:24-36.
15. Thybo NK, Korsgaard N, Mulvany MJ. Morphology and function of mesenteric resistance arteries in transgenic rats with low-renin hypertension. J Hypertens. 1992;10:1191-1196.
16. Baumbach GL, Heistad DD. Remodelling of cerebral arterioles in chronic hypertension. Hypertension. 1989;13:968-972.
17. Baumbach GL, Hajdu MA. Mechanics and composition of cerebral arterioles in renal and spontaneously hypertensive rats. Hypertension. 1993;21:816-826.
18. Hajdu MA, Baumbach GL. Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol. 1994;266:H1027-H1033.
19. Dunn WR, Gardiner SM. No evidence for vascular remodelling during hypertension induced by chronic inhibition of nitric oxide synthase in Brattleboro rats. J Hypertens. 1995;13:849-857.
20. Dunn WR, Gardiner SM. Structural and functional properties of isolated, pressurized, mesenteric resistance arteries from a vasopressin-deficient rat model of genetic hypertension. Hypertension. 1995;26:390-396.
21. Halpern W, Osol G, Coy GS. Mechanical behaviour of pressurized in vitro pre-arteriolar vessels determined with a video system. Ann Biomed Eng. 1984;12:463-479.
22. Baumbach GL, Heistad DD. Adaptive changes in cerebral blood vessels during chronic hypertension. J Hypertens. 1991;9:987-991.
23. Mulvany MJ. Are vascular abnormalities a primary cause or secondary consequence of hypertension? Hypertension. 1991;18(suppl I):I-52-I-57.
24. Mulvany MJ. Resistance vessel structure in hypertension: growth or remodelling? Cardiovasc Pharmacol. 1993;22(suppl 5):S44-S47.
25. Heagerty AM, Aalkjaer C, Bund S, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual process of remodelling and growth. Hypertension. 1993;21:391-397.
26. Folkow B. Early structural changes in hypertension: pathophysiology and clinical consequences. J Cardiovasc Pharmacol. 1993; 22(suppl 1):S1-S6.
27. Winquist RJ, Bohr DF. Structural and functional changes in cerebral arteries from spontaneously hypertensive rats. Hypertension. 1983;5:292-297.
28. G-nitro-L-arginine methyl ester: methodological considerations for studies of small arteries in hypertension. J Hypertens. 1995;13:1217-1221. Reply.
29. Brayden JE, Halpern W, Brann LR. Biochemical and mechanical properties of resistance arteries from normotensive and hypertensive rats. Hypertension. 1983;5:17-25.
30. Piero C, De Sagarra MR, Redondo J, Sanchez-Ferrer CF, Marin J. Vascular smooth muscle proliferation in hypertensive transgenic rats. J Cardiovasc Pharmacol. 1992;20(suppl 12):S128-S131.
31. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy. J Hypertens. 1991;9:3-15.
32. Schiffrin EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension. 1995;25:1135-1143.